Results 191 to 200 of about 74,566 (254)

Modulation of Tropomyosin Receptor Kinase for the Treatment of Neurotrophin Diseases: Alzheimer's, Huntington's and Parkinson's. [PDF]

ACS Med Chem Lett, 2019
Kargbo RB.
europepmc   +1 more source

Correction to "Induction of Resistance to Neurotrophic Tropomyosin-Receptor Kinase Inhibitors by HMGCS2 via a Mevalonate Pathway". [PDF]

Cancer Med
europepmc   +1 more source

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer. [PDF]

Pathol Oncol Res, 2020
Wong D, Yip S, Sorensen PH.
europepmc   +1 more source

[Protective Effects of Secoisolarciresinol Digucoside on Trans Fatty Acid-Induced Brain Inflammation and Oxidative Stress in Offspring Mice and Changes in Brain-Derived Neurotrophic Factor 28 and Tropomyosin Receptor Kinase B]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Ma S, Zhu R, Jiang M, Zhao W.
europepmc   +1 more source

Use of a tropomyosin receptor kinase inhibitor to successfully treat an infant with metastatic pineoblastoma

Pediatrics & Neonatology
Chia-Yu Cheng, Muh-Lii Liang, Hsi-Che Liu, Jen-Yin Hou, Jia-Yun Huang, Chun-Chao Huang, Ting-Chi Yeh   +6 more
openaire   +2 more sources

Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors. [PDF]

Ann Transl Med, 2019
Mamdani H, Jalal SI.
europepmc   +1 more source